Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
US4978332A · kind A · utility
48Cited by
10References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 1987 |
| Grant date | Dec 18, 1990 |
| Priority date | — |
| Expiry date | Sep 28, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition and method of treating cellular disorders involving abnormal solid cellular growths which comprises administering a pharmaceutical composition containing cytotoxic agents in combination with a vasoconstrictive drug. Enhanced effectiveness of the composition is observed, with reduced cytotoxic effects on cells distant from the site of introduction. Agents may be included to enhance therapeutic gain and reduce adverse affects to normal tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.